Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone therapy for endometrial cancer prevention in obese women
ISRCTN40940943Phase 2Completed
- Sponsor
- National Institute for Health and Care Research
- Start
- May 2015
- Modality
- Small Molecules
01
Overview
Phase 2, open-label trial of avatrombopag in endometrial cancer (EC), sponsored by National Institute for Health and Care Research. Primary endpoint: Ki-67. Started May 2015; status: completed.
02
Drugs
avatrombopag
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on ISRCTN40940943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN40940943.